REGN·75886F107·US·equity·Healthcare - Biotechnology-13D/G
REGN (REGENERON PHARMACEUTICALS) is held by 321 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($6.9B), STATE STREET CORP ($3.6B), DODGE & COX ($3.4B). Net institutional sentiment: Mixed.
See how REGN's score breaks down across 4 SEC sources
Showing 1-20 of 337
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer